Angela Listì

1.9k total citations
41 papers, 1.3k citations indexed

About

Angela Listì is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Angela Listì has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Angela Listì's work include Lung Cancer Treatments and Mutations (23 papers), Colorectal Cancer Treatments and Studies (12 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Angela Listì is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Colorectal Cancer Treatments and Studies (12 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Angela Listì collaborates with scholars based in Italy, Belgium and Chile. Angela Listì's co-authors include Viviana Bazan, Francesco Passiglia, Daniele Fanale, Antonio Russo, Antonio Galvano, Sérgio Rizzo, Lorena Incorvaia, Nadia Barraco, Marta Castiglia and Valentina Calò and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Scientific Reports.

In The Last Decade

Angela Listì

41 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angela Listì Italy	19	701	538	420	331	180	41	1.3k
Sònia Pernas Spain	20	1.1k 1.6×	447 0.8×	413 1.0×	545 1.6×	98 0.5×	109	1.6k
Yun Jung Choi South Korea	18	530 0.8×	349 0.6×	751 1.8×	372 1.1×	262 1.5×	45	1.4k
Chung-Tsen Hsueh United States	19	556 0.8×	305 0.6×	416 1.0×	200 0.6×	87 0.5×	55	1.2k
Tao Sun China	19	672 1.0×	451 0.8×	379 0.9×	185 0.6×	100 0.6×	92	1.4k
Ricardo Costa United States	22	1.1k 1.6×	601 1.1×	848 2.0×	540 1.6×	268 1.5×	82	2.2k
Marta Castiglia Italy	22	619 0.9×	518 1.0×	730 1.7×	608 1.8×	75 0.4×	52	1.5k
Patrick G. Pilié United States	13	1.1k 1.5×	407 0.8×	1.1k 2.6×	342 1.0×	227 1.3×	43	1.8k
Ximing Xu China	24	527 0.8×	324 0.6×	896 2.1×	599 1.8×	198 1.1×	101	1.6k
Siyuan Weng China	18	523 0.7×	530 1.0×	717 1.7×	442 1.3×	314 1.7×	75	1.5k
Marileila Varella‐Garcia United States	13	623 0.9×	860 1.6×	618 1.5×	277 0.8×	68 0.4×	16	1.4k

Countries citing papers authored by Angela Listì

Since Specialization

Citations

This map shows the geographic impact of Angela Listì's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Listì with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Listì more than expected).

Fields of papers citing papers by Angela Listì

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Listì. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Listì. The network helps show where Angela Listì may publish in the future.

Co-authorship network of co-authors of Angela Listì

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Listì. A scholar is included among the top collaborators of Angela Listì based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Listì. Angela Listì is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Passiglia, Francesco, Luisella Righi, Paolo Bironzo, et al.. (2023). Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial. Clinical Cancer Research. 30(5). 959–964. 12 indexed citations

Bironzo, Paolo, Angela Listì, Francesco Passiglia, et al.. (2023). Real‐world retrospective study of KRAS mutations in advanced non–small cell lung cancer in the era of immunotherapy. Cancer. 129(11). 1662–1671. 6 indexed citations

Passiglia, Francesco, et al.. (2022). Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review. Translational Lung Cancer Research. 11(5). 935–949. 10 indexed citations

Napoli, Francesca, Angela Listì, Vanessa Zambelli, et al.. (2021). Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma. Cancers. 13(11). 2564–2564. 16 indexed citations

Bironzo, Paolo, Maria Lucia Reale, Fabrizio Tabbò, et al.. (2021). Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations. Cancers. 13(10). 2425–2425. 9 indexed citations

Malapelle, Umberto, Sara Pilotto, Francesco Passiglia, et al.. (2021). Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective. Critical Reviews in Oncology/Hematology. 160. 103300–103300. 12 indexed citations

Borrello, María Teresa, Maria Rita Emma, Angela Listì, et al.. (2021). NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response. The FASEB Journal. 35(3). e21395–e21395. 12 indexed citations

Righi, Luisella, Alberto Righi, Simona Vatrano, et al.. (2021). Primary lung adenocarcinoma in three adolescent patients affected by bone sarcomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 478(6). 1125–1134. 1 indexed citations

Incorvaia, Lorena, Daniele Fanale, Giuseppe Badalamenti, et al.. (2019). Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC). Advances in Therapy. 36(10). 2600–2617. 76 indexed citations

10.

Badalamenti, Giuseppe, Daniele Fanale, Lorena Incorvaia, et al.. (2018). Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?. Cellular Immunology. 343. 103753–103753. 167 indexed citations

11.

Passiglia, Francesco, Massimo Di Maïo, Antonio Galvano, et al.. (2018). P1.13-16 The Diagnostic Accuracy of Circulating Tumor DNA for the Detection of EGFR-T790M Mutation in NSCLC: A Systematic Review and Meta-Analysis. Journal of Thoracic Oncology. 13(10). S588–S588. 1 indexed citations

12.

Passiglia, Francesco, Sérgio Rizzo, Massimo Di Maïo, et al.. (2018). Publisher Correction: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis. Scientific Reports. 8(1). 17270–17270. 6 indexed citations

13.

Passiglia, Francesco, Christian Caglevic, Elisa Giovannetti, et al.. (2018). Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment. Seminars in Cancer Biology. 52(Pt 2). 259–268. 10 indexed citations

14.

Paglia, Laura La, Angela Listì, Stefano Caruso, et al.. (2017). Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway. PPAR Research. 2017. 1–15. 129 indexed citations

15.

Corrales, Luis, Amanda Nogueira, Francesco Passiglia, et al.. (2017). Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib. Frontiers in Medicine. 4. 13–13. 16 indexed citations

16.

Bronte, Giuseppe, Lorena Incorvaia, Sérgio Rizzo, et al.. (2016). The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?. Critical Reviews in Oncology/Hematology. 107. 20–32. 24 indexed citations

17.

Passiglia, Francesco, Rafael Caparica, Elisa Giovannetti, et al.. (2016). The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer. Expert Opinion on Investigational Drugs. 25(4). 385–392. 23 indexed citations

18.

Fanale, Daniele, Nadia Barraco, Angela Listì, Viviana Bazan, & Antonio Russo. (2016). Non-coding RNAs Functioning in Colorectal Cancer Stem Cells. Advances in experimental medicine and biology. 937. 93–108. 22 indexed citations

19.

Fanale, Daniele, Giuseppe Bronte, Francesco Passiglia, et al.. (2015). Stabilizing versus Destabilizing the Microtubules: A Double-Edge Sword for an Effective Cancer Treatment Option?. Analytical Cellular Pathology. 2015. 1–19. 95 indexed citations

20.

Passiglia, Francesco, Giuseppe Bronte, Marta Castiglia, et al.. (2015). Prognostic and predictive biomarkers for targeted therapy in NSCLC: for whom the bell tolls?. Expert Opinion on Biological Therapy. 15(11). 1553–1566. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact